Kalaris Therapeutics, Inc. (KLRS)
9.13
-1.29
(-12.38%)
USD |
NASDAQ |
Dec 19, 16:00
9.41
+0.28
(+3.07%)
After-Hours: 04:53
Kalaris Therapeutics Price: 9.13 for Dec. 19, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CEL-SCI Corp. | 4.91 |
| AIM ImmunoTech, Inc. | 1.42 |
| IGC Pharma, Inc. | 0.30 |
| NovaBay Pharmaceuticals, Inc. | 5.30 |
| Protalix Biotherapeutics, Inc. | 1.73 |
Price Related Metrics
| Price to Book Value | 4.079 |
| Earnings Yield | -81.02% |
| Market Cap | 170.75M |